Info
- Utilizzare la checkbox di selezione a fianco di ciascun documento per attivare le funzionalità di stampa, invio email, download nei formati disponibili del (i) record.
Applied Statistics in Biomedicine and Clinical Trials Design : Selected Papers from 2013 ICSA/ISBS Joint Statistical Meetings / / edited by Zhen Chen, Aiyi Liu, Yongming Qu, Larry Tang, Naitee Ting, Yi Tsong
| Applied Statistics in Biomedicine and Clinical Trials Design : Selected Papers from 2013 ICSA/ISBS Joint Statistical Meetings / / edited by Zhen Chen, Aiyi Liu, Yongming Qu, Larry Tang, Naitee Ting, Yi Tsong |
| Edizione | [1st ed. 2015.] |
| Pubbl/distr/stampa | Cham : , : Springer International Publishing : , : Imprint : Springer, , 2015 |
| Descrizione fisica | 1 online resource (550 p.) |
| Disciplina |
610.2/1
610.21 |
| Collana | ICSA Book Series in Statistics |
| Soggetto topico |
Biometry
Statistics Medicine - Research Biology - Research Biostatistics Statistical Theory and Methods Biomedical Research |
| ISBN | 3-319-12694-6 |
| Formato | Materiale a stampa  |
| Livello bibliografico | Monografia |
| Lingua di pubblicazione | eng |
| Nota di contenuto | Bayesian Methods in Biomedical Research -- Diagnostic Medicine and Classification -- Innovative Clinical Trials Design and Analysis -- Modeling and Data Analysis -- Personalized Medicine -- Statistical Genomics and High-Dimensional Data Analysis. |
| Record Nr. | UNINA-9910299763103321 |
| Cham : , : Springer International Publishing : , : Imprint : Springer, , 2015 | ||
| Materiale a stampa | ||
| Lo trovi qui: Univ. Federico II | ||
| ||
Pharmaceutical Statistics : MBSW 39, Muncie, Indiana, USA, May 16-18, 2016 / / edited by Ray Liu, Yi Tsong
| Pharmaceutical Statistics : MBSW 39, Muncie, Indiana, USA, May 16-18, 2016 / / edited by Ray Liu, Yi Tsong |
| Edizione | [1st ed. 2019.] |
| Pubbl/distr/stampa | Cham : , : Springer International Publishing : , : Imprint : Springer, , 2019 |
| Descrizione fisica | 1 online resource (330 pages) |
| Disciplina | 615.1072 |
| Collana | Springer Proceedings in Mathematics & Statistics |
| Soggetto topico |
Statistics
Biostatistics Pharmaceutical technology Statistics for Life Sciences, Medicine, Health Sciences Pharmaceutical Sciences/Technology Statistical Theory and Methods |
| ISBN | 3-319-67386-6 |
| Formato | Materiale a stampa |
| Livello bibliografico | Monografia |
| Lingua di pubblicazione | eng |
| Nota di contenuto | Part I: Specification and Sampling Acceptance Tests -- Statistical Considerations in Setting Quality Specification Limits Using Quality Data -- Counting Test and Parametric Two One-Sided Tolerance Interval Test for Content Uniformity Using Large Sample Sizes -- Part II: Analytical Biosimilar and Process Validation -- Sample Size Consideration for Equivalent Test of Tier-1 Quality Attributes for Analytical Biosimilarity Assessment -- A Probability Based Equivalence Test of NIR Versus HPLC Analytical Methods in a Continuous Manufacturing Process Validation Study -- A Further Look at the Current Equivalence Test for Analytical Similarity Assessment -- Shiny Tools for Sample Size Calculation in Process Performance Qualification of Large Molecules -- Part III: Continuous Process -- Risk Evaluation of Registered Specifications and Internal Release Limits Using a Bayesian Approach -- Development of Statistical Computational Tools Through Pharmaceutical Drug Development and Manufacturing Life Cycle -- Application of Advanced Statistical Tools to Achieve Continuous Analytical Verification: A Risk Assessment Case of the Impact of Analytical Method Performance on Process Performance Using a Bayesian Approach -- Part IV: Clinical Trial Design and Analysis -- Exact Inference for Adaptive Group Sequential Designs -- A Novel Framework for Bayesian Response-Adaptive Randomization -- Sample Size Determination Under Non-proportional Hazards -- Adaptive Three-Stage Clinical Trial Design for a Binary Endpoint in the Rare Disease Setting -- Part V: Biomarker-Driven Trial Design -- Clinical Trial Designs to Evaluate Predictive Biomarkers: What’s Being Estimated? -- Biomarker Enrichment Design Considerations in Oncology Single Arm Studies -- Challenges of Bridging Studies in Biomarker Driven Clinical Trials: The Impact of Companion Diagnostic Device Performance on Clinical Efficacy -- Part VI: Application of Novel Data Modality -- Parallel-Tempered Feature Allocation for Large-Scale Tumor Heterogeneity with Deep Sequencing Data -- Analysis of T-Cell Immune Responses as Measured by Intracellular Cytokine Staining with Application to Vaccine Clinical Trials -- Project Data Sphere and the Applications of Historical Patient Level Clinical Trial Data in Oncology Drug Development -- Novel Test for the Equality of Continuous Curves with Homoscedastic or Heteroscedastic Measurement Errors -- Quality Control Metrics for Extraction-Free Targeted RNA-Seq Under a Compositional Framework -- Part VII: Omics Data Analysis -- Leveraging Omics Biomarker Data in Drug Development: With a GWAS Case Study -- A Simulation Study Comparing SNP Based Prediction Models of Drug Response. |
| Record Nr. | UNINA-9910338247503321 |
| Cham : , : Springer International Publishing : , : Imprint : Springer, , 2019 | ||
| Materiale a stampa | ||
| Lo trovi qui: Univ. Federico II | ||
| ||